Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/7682427

Download in:

View as

General Info

PMID
7682427